{
  "experiment_id": "3b0d497c9f90f6ba1b330e8a68238661",
  "task_name": "broadening_of_narrow_synonyms",
  "task_hash": "9082f66c620d0bc6fea9232b665ebcbe",
  "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "timestamp": "2025-11-13T03:54:14.039876",
  "task_result": {
    "task_name": "broadening_of_narrow_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 microdeletion syndrome",
          "assay": "clinical whole-exome sequencing",
          "tumorType": "Plexiform neurofibroma (morphologic abnormality)"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3052,
            "output_tokens": 75
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01ULH28Mr57SNesEm4WU6Yia",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Plexiform Neurofibroma\"\n}"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3052,
              "output_tokens": 75
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3052,
          "output_tokens": 75,
          "total_tokens": 3127
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with optic pathway glioma",
          "assay": "Illumina whole exome sequencing ",
          "tumorType": "malignant triton tumor"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": Changed from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\". The optic pathway glioma is a specific manifestation of NF1, but the broader diagnosis term is used as per the schema.\n\n2. \"assay\": Changed from \"Illumina whole exome sequencing\" to \"whole exome sequencing\". The brand name \"Illumina\" was removed to use the more general term that matches the schema.\n\n3. \"tumorType\": Changed from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\". A malignant triton tumor is a specific type of Malignant Peripheral Nerve Sheath Tumor (MPNST), so the broader term from the schema is used.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3047,
            "output_tokens": 280
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01NyC7CDCsN9f2GopoyMD1Mg",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": Changed from \"Neurofibromatosis type 1 with optic pathway glioma\" to \"Neurofibromatosis type 1\". The optic pathway glioma is a specific manifestation of NF1, but the broader diagnosis term is used as per the schema.\n\n2. \"assay\": Changed from \"Illumina whole exome sequencing\" to \"whole exome sequencing\". The brand name \"Illumina\" was removed to use the more general term that matches the schema.\n\n3. \"tumorType\": Changed from \"malignant triton tumor\" to \"Malignant Peripheral Nerve Sheath Tumor\". A malignant triton tumor is a specific type of Malignant Peripheral Nerve Sheath Tumor (MPNST), so the broader term from the schema is used."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "output_tokens": 280
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 280,
          "total_tokens": 3327
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Watson Syndrome",
          "assay": "MGI whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation"
        },
        "response": {
          "success": true,
          "content": "I've reviewed the input data and the target schema. I'll now broaden the narrow synonyms to match the controlled terminology in the schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"Watson Syndrome\" was changed to \"Noonan Syndrome\". Watson Syndrome is considered a variant of Noonan Syndrome, so this is the closest match in the controlled terminology.\n\n2. \"assay\": \"MGI whole genome sequencing\" was simplified to \"whole genome sequencing\" to match the exact term in the schema.\n\n3. \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" was broadened to \"Malignant Peripheral Nerve Sheath Tumor\" to match the exact term in the schema. The schema doesn't include a more specific category for MPNST with mesenchymal differentiation.\n\nThese changes ensure that all values match the controlled terminology specified in the target schema while maintaining the most accurate representation of the original data.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3046,
            "output_tokens": 288
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_018vXzgKrZYsmbwqoPDWRhB1",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "I've reviewed the input data and the target schema. I'll now broaden the narrow synonyms to match the controlled terminology in the schema. Here's the corrected metadata:\n\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"Watson Syndrome\" was changed to \"Noonan Syndrome\". Watson Syndrome is considered a variant of Noonan Syndrome, so this is the closest match in the controlled terminology.\n\n2. \"assay\": \"MGI whole genome sequencing\" was simplified to \"whole genome sequencing\" to match the exact term in the schema.\n\n3. \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation\" was broadened to \"Malignant Peripheral Nerve Sheath Tumor\" to match the exact term in the schema. The schema doesn't include a more specific category for MPNST with mesenchymal differentiation.\n\nThese changes ensure that all values match the controlled terminology specified in the target schema while maintaining the most accurate representation of the original data."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3046,
              "output_tokens": 288
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3046,
          "output_tokens": 288,
          "total_tokens": 3334
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurofibromatosis, familial spinal",
          "assay": "open MRI",
          "tumorType": "unknown - no information available"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurofibromatosis, familial spinal\" was broadened to \"Neurofibromatosis type 1\", which is the closest match in the provided enum list for diagnosis.\n\n2. \"assay\": \"open MRI\" was broadened to \"conventional MRI\", which is the most appropriate match from the assay enum list.\n\n3. \"tumorType\": \"unknown - no information available\" was simplified to \"Unknown\", which is the exact match from the tumorType enum list.\n\nThese changes ensure that all values match the controlled terminology specified in the Target Schema while maintaining the original meaning as closely as possible.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3034,
            "output_tokens": 215
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_0177MvujcB6QUiFmJJy832j4",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurofibromatosis, familial spinal\" was broadened to \"Neurofibromatosis type 1\", which is the closest match in the provided enum list for diagnosis.\n\n2. \"assay\": \"open MRI\" was broadened to \"conventional MRI\", which is the most appropriate match from the assay enum list.\n\n3. \"tumorType\": \"unknown - no information available\" was simplified to \"Unknown\", which is the exact match from the tumorType enum list.\n\nThese changes ensure that all values match the controlled terminology specified in the Target Schema while maintaining the original meaning as closely as possible."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "output_tokens": 215
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 215,
          "total_tokens": 3249
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry of skin",
          "tumorType": "Cutaneous storiform neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms matching the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nChanges made:\n1. \"diagnosis\" was already correct, so no change was needed.\n2. \"assay\" was broadened from \"immunohistochemistry of skin\" to simply \"immunohistochemistry\" to match the controlled terminology.\n3. \"tumorType\" was broadened from \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" to match the controlled terminology. The term \"storiform\" was removed as it's not part of the standard terms in the schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3034,
            "output_tokens": 182
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_012nk6qzFqTewZDtzw4dSJ6R",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms matching the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunohistochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nChanges made:\n1. \"diagnosis\" was already correct, so no change was needed.\n2. \"assay\" was broadened from \"immunohistochemistry of skin\" to simply \"immunohistochemistry\" to match the controlled terminology.\n3. \"tumorType\" was broadened from \"Cutaneous storiform neurofibroma\" to \"Cutaneous Neurofibroma\" to match the controlled terminology. The term \"storiform\" was removed as it's not part of the standard terms in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3034,
              "output_tokens": 182
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3034,
          "output_tokens": 182,
          "total_tokens": 3216
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "chromosome 17q11.2 deletion syndrome, 1.4Mb",
          "assay": "cell viability assay using Annexin V staining",
          "tumorType": "Pedunculated Cutaneous Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" was broadened to \"Neurofibromatosis type 1\", which is the standard term for this condition in the provided schema.\n\n2. \"assay\": \"cell viability assay using Annexin V staining\" was broadened to \"cell viability assay\", which is the exact term listed in the schema's controlled vocabulary.\n\n3. \"tumorType\": \"Pedunculated Cutaneous Neurofibroma\" was broadened to \"Cutaneous Neurofibroma\", which is the closest matching term in the schema's controlled vocabulary for tumor types.\n\nThese changes ensure that the metadata uses standardized, broader terms that match the exact values specified in the Target Schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3056,
            "output_tokens": 257
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01SkBmE6Dn6LvGgweZAfbbKe",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"chromosome 17q11.2 deletion syndrome, 1.4Mb\" was broadened to \"Neurofibromatosis type 1\", which is the standard term for this condition in the provided schema.\n\n2. \"assay\": \"cell viability assay using Annexin V staining\" was broadened to \"cell viability assay\", which is the exact term listed in the schema's controlled vocabulary.\n\n3. \"tumorType\": \"Pedunculated Cutaneous Neurofibroma\" was broadened to \"Cutaneous Neurofibroma\", which is the closest matching term in the schema's controlled vocabulary for tumor types.\n\nThese changes ensure that the metadata uses standardized, broader terms that match the exact values specified in the Target Schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3056,
              "output_tokens": 257
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3056,
          "output_tokens": 257,
          "total_tokens": 3313
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "Neurofibromatosis type 1 with scoliosis",
          "assay": "anti-tag immunocytochemistry",
          "tumorType": "sessile cutaneous neurofibroma"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"diagnosis\": Removed the specific symptom \"with scoliosis\" to match the broader term in the schema.\n2. \"assay\": Removed the specific \"anti-tag\" qualifier to match the broader term in the schema.\n3. \"tumorType\": Changed \"sessile cutaneous neurofibroma\" to the broader term \"Cutaneous Neurofibroma\" as specified in the schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3047,
            "output_tokens": 175
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01KEMWQewzMRfqbD3rBUZnCR",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunocytochemistry\",\n  \"tumorType\": \"Cutaneous Neurofibroma\"\n}\n\nExplanations for the changes:\n1. \"diagnosis\": Removed the specific symptom \"with scoliosis\" to match the broader term in the schema.\n2. \"assay\": Removed the specific \"anti-tag\" qualifier to match the broader term in the schema.\n3. \"tumorType\": Changed \"sessile cutaneous neurofibroma\" to the broader term \"Cutaneous Neurofibroma\" as specified in the schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3047,
              "output_tokens": 175
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3047,
          "output_tokens": 175,
          "total_tokens": 3222
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "neurofibromatosis, peripheral type",
          "assay": "wide bore MRI",
          "tumorType": "no clear diagnosis"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurofibromatosis, peripheral type\" was broadened to \"Neurofibromatosis type 1\", which is the standard term in the Target Schema for this condition.\n\n2. \"assay\": \"wide bore MRI\" was broadened to \"conventional MRI\", which is the closest matching term in the Target Schema for this type of imaging.\n\n3. \"tumorType\": \"no clear diagnosis\" was changed to \"Unknown\", as this is the most appropriate term from the Target Schema when there is no specific tumor type identified.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3031,
            "output_tokens": 196
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01JBmAEyxmi5r51LbXtU4e7H",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"neurofibromatosis, peripheral type\" was broadened to \"Neurofibromatosis type 1\", which is the standard term in the Target Schema for this condition.\n\n2. \"assay\": \"wide bore MRI\" was broadened to \"conventional MRI\", which is the closest matching term in the Target Schema for this type of imaging.\n\n3. \"tumorType\": \"no clear diagnosis\" was changed to \"Unknown\", as this is the most appropriate term from the Target Schema when there is no specific tumor type identified."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "output_tokens": 196
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 196,
          "total_tokens": 3227
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "acoustic neurofibromatosis",
          "assay": "RNA-seq with ribosomal RNA depletion",
          "tumorType": "Acoustic neuroma of left vestibular nerve"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"acoustic neurofibromatosis\" was broadened to \"NF2-related schwannomatosis\", which is the closest match in the provided enum list for diagnosis.\n\n2. \"assay\": \"RNA-seq with ribosomal RNA depletion\" was simplified to \"RNA-seq\", as this is the exact term available in the assay enum list.\n\n3. \"tumorType\": \"Acoustic neuroma of left vestibular nerve\" was broadened to \"Schwannoma\", which is the most appropriate general term available in the tumorType enum list. An acoustic neuroma is a type of schwannoma.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3044,
            "output_tokens": 219
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_0131phJ7gAaYZkVk9quRncxM",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"NF2-related schwannomatosis\",\n  \"assay\": \"RNA-seq\",\n  \"tumorType\": \"Schwannoma\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": \"acoustic neurofibromatosis\" was broadened to \"NF2-related schwannomatosis\", which is the closest match in the provided enum list for diagnosis.\n\n2. \"assay\": \"RNA-seq with ribosomal RNA depletion\" was simplified to \"RNA-seq\", as this is the exact term available in the assay enum list.\n\n3. \"tumorType\": \"Acoustic neuroma of left vestibular nerve\" was broadened to \"Schwannoma\", which is the most appropriate general term available in the tumorType enum list. An acoustic neuroma is a type of schwannoma."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3044,
              "output_tokens": 219
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3044,
          "output_tokens": 219,
          "total_tokens": 3263
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "neurofibromatosis type 1 due to NF1 mutation or intragenic deletion",
          "assay": "CellTiter-Glo\u00ae 3D Cell Viability Assay",
          "tumorType": "Epithelioid Malignant Peripheral Nerve Sheath Tumor"
        },
        "response": {
          "success": true,
          "content": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": The specific \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" was broadened to the more general \"Neurofibromatosis type 1\" which is an exact match from the schema's enumerated values.\n\n2. \"assay\": The specific \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" was broadened to the more general \"cell viability assay\" which is an exact match from the schema's enumerated values.\n\n3. \"tumorType\": The specific \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" was broadened to the more general \"Malignant Peripheral Nerve Sheath Tumor\" which is an exact match from the schema's enumerated values.\n\nThese changes ensure that the metadata uses standardized, broader terms that conform to the controlled terminology specified in the Target Schema.",
          "model_id": "us.anthropic.claude-3-5-sonnet-20240620-v1:0",
          "usage": {
            "input_tokens": 3077,
            "output_tokens": 298
          },
          "attempt": 1,
          "raw_response": {
            "id": "msg_bdrk_01QQVoU6DRn7s9ib931s3r94",
            "type": "message",
            "role": "assistant",
            "model": "claude-3-5-sonnet-20240620",
            "content": [
              {
                "type": "text",
                "text": "Here is the corrected metadata with broadened terms that match the controlled terminology in the Target Schema:\n\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n\nExplanations for the changes:\n\n1. \"diagnosis\": The specific \"neurofibromatosis type 1 due to NF1 mutation or intragenic deletion\" was broadened to the more general \"Neurofibromatosis type 1\" which is an exact match from the schema's enumerated values.\n\n2. \"assay\": The specific \"CellTiter-Glo\u00ae 3D Cell Viability Assay\" was broadened to the more general \"cell viability assay\" which is an exact match from the schema's enumerated values.\n\n3. \"tumorType\": The specific \"Epithelioid Malignant Peripheral Nerve Sheath Tumor\" was broadened to the more general \"Malignant Peripheral Nerve Sheath Tumor\" which is an exact match from the schema's enumerated values.\n\nThese changes ensure that the metadata uses standardized, broader terms that conform to the controlled terminology specified in the Target Schema."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3077,
              "output_tokens": 298
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3077,
          "output_tokens": 298,
          "total_tokens": 3375
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.8999999999999998,
      "min_score": 0.6666666666666666,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 55.448267221450806,
    "token_usage": {
      "input_tokens": 30468,
      "output_tokens": 2185,
      "total_tokens": 32653
    }
  }
}